Dictyostelium Mutants

Phenotypes for Dictyostelium mutants

View other mutant types: All mutant strains - Null - Overexpression - Multiple - Other - Developmental

To view more details, including parent strains and references, click on the corresponding dictyBase ID.

Systematic Name	Strain Descriptor	Associated gene(s)	Phenotypes
DBS0350657	[csaA]: csaA	csaA	aberrant aggregation \| increased calcium-independent cell-cell adhesion
DBS0235594	CHE10	cbpC	decreased slug migration \| precocious aggregation \| decreased aggregate size \| decreased fruiting body size \| delayed culmination
DBS0266719	Dd5P4-/ [act15]: Dd5P4: GFP	Dd5P4	wild type
DBS0266695	Dd5P4-/ [act15]: GAP5P4	Dd5P4	decreased growth rate \| multiple tips in mound
DBS0266720	Dd5P4-/ [act15]: Hs-OCRL	Dd5P4	decreased phagocytosis
DBS0266721	Dd5P4-/ [act15]: Hs-OCRL(D422A)	Dd5P4	decreased phagocytosis
DBS0266694	Dd5P4-/ [act15]: cat5P4	Dd5P4	decreased growth rate \| multiple tips in mound
CW0391	FLAG-VwkA	vwkA	increased myosin II assembly \| aberrant response to hypo-osmotic stress \| decreased growth rate \| aberrant cytokinesis \| development arrests at mound stage \| increased protein level
CW0368	GFP-VwkA	vwkA	decreased growth rate \| aberrant cytokinesis
DBS0350102	GFP: pcp	pcp	aberrant response to hypo-osmotic stress \| aberrant contractile vacuole morphology
DBS0236358	HR42	fbxA	abolished culmination \| decreased sporulation
DBS0237044	VatMpr/ [act15]: vatM	vatM	wild type
DBS0237042	VatMpr/ [act15]: vatM: GFP	vatM	decreased growth rate
DBS0238036	[AS]proA/ proB-/ [act15]: proA	proA \| proB	wild type
DBS0238037	[AS]proA/ proB-/ [act15]: proB	proA \| proB	wild type
DBS0238035	[AS]proA/ proB-/ [unk]: FLAG: proC	proA \| proB \| proC	wild type
DBS0237274	[OE]: chlim	ChLim	increased basal F-actin level \| decreased phagocytosis \| decreased growth rate
DBS0350519	[OE]: egeA	egeA	decreased protein level \| abolished aggregation
DBS0237275	[OE]: gbfA	gbfA	precocious gene expression
JH258	[OE]: gpaE	gpaE	precocious tip formation \| precocious gene expression
DBS0348921	[OE]: ipkA1	ipkA1	aberrant inositol phosphate metabolic process \| decreased response to lithium \| aberrant gene expression
DBS0348922	[OE]: itpk1	itpk1	aberrant inositol phosphate metabolic process \| decreased response to lithium \| aberrant gene expression
DBS0236962	[OE]: pdiA	pdiA	delayed aggregation
DBS0237015	[OE]: pdiA	pdiA	aberrant tip formation \| abolished slug formation \| abolished culmination
DBS0302681	[OE]: sgcA(878-2843): GFP/ sgcA-	gcA \| sgcA	aberrant chemotaxis to cAMP \| decreased chemotaxis rate
DBS0302682	[OE]: sgcA(N1106A): GFP/ gca-/ sgcA-	gcA \| sgcA	aberrant streaming \| aberrant chemotaxis to cAMP \| increased lateral pseudopod formation \| decreased chemotaxis rate
DBS0266621	[OE]mipp1	mipp1	aberrant inositol phosphate metabolic process \| aberrant gene expression \| increased response to lithium
DBS0349923	[RNAi]ctnnA/ [act15]: GFP-mhcA	ctnnA	aberrant stalk morphogenesis \| aberrant protein localization
DBS0350924	[TRE-Pmin]: 6xHis: GFP: dhcA(1384-4725(K1975T))	dhcA	aberrant molecular function
DBS0350052	[TRE-Pmin]: arfA(Q71L): GFP	arfA	aberrant filopodium formation \| aberrant cytokinesis
DBS0350053	[TRE-Pmin]: arfA(T31N): GFP	arfA	wild type \| decreased infection rate by a gram-negative pathogenic bacterium
DBS0350674	[act15]: 6xHis: erkA	erkA	aberrant slug formation
DBS0349845	[act15]: 7xHis: myoK: Ty1	myoK	aberrant cortical actin cytoskeleton stabilization \| aberrant engulfment during phagocytosis \| aberrant cell morphology
DBS0237100	[act15]: CFP: racC(G15V)	racC	increased basal F-actin level
DBS0266512	[act15]: DDB_G0272656	sigN4	wild type
DBS0350978	[act15]: DDB_G0285969	DDB_G0285969	increased pinocytosis \| increased growth rate \| increased phagocytosis
DBS0350049	[act15]: FLAG: cycC	cycC	precocious tip formation
DBS0350321	[act15]: FLAG: hbx4	hbx4	aberrant aggregation \| abolished gene expression \| abolished slug migration \| decreased growth rate \| aberrant cytokinesis
DBS0350322	[act15]: FLAG: hbx4/ [act15]: cadA	cadA \| hbx4	wild type
DBS0350325	[act15]: FLAG: hbx4/ [ecmAO]: lacZ	hbx4	decreased spore viability \| aberrant gene expression \| increased prestalk cell differentiation
DBS0238107	[act15]: FLAG: ppp4C	ppp4c	wild type
DBS0238108	[act15]: FLAG: ppp4C(H113Q)	ppp4c	development arrests at mound stage \| delayed development
DBS0304572	[act15]: GFP: abpD(1441-1736)	abpD	abolished localization to nuclear envelope
DBS0304571	[act15]: GFP: abpD(1441-1738)	abpD	abolished protein localization to nuclear envelope \| abolished localization to nuclear envelope
DBS0304573	[act15]: GFP: abpD(1441-1738,1737P/ A)	abpD	abolished localization to nuclear envelope
DBS0237114	[act15]: GFP: abpE(413-481)	abpE-1 \| abpE-2	increased lateral pseudopod formation
DBS0350593	[act15]: GFP: cepL	cepL	decreased cell polarity \| decreased growth rate \| decreased phagocytosis \| increased cell size \| increased cell-substrate adhesion \| aberrant centrosome localization
DBS0350594	[act15]: GFP: cepL(1-1114)	cepL	increased number of centrosomes \| decreased growth rate \| aberrant vegetative growth \| increased fruiting body size \| decreased phagocytosis \| increased cell-substrate adhesion \| decreased chemotaxis rate \| aberrant phototaxis
DBS0350595	[act15]: GFP: cepL(1-763)	cepL	increased number of centrosomes \| decreased growth rate \| aberrant vegetative growth \| increased fruiting body size \| decreased phagocytosis \| increased cell-substrate adhesion \| decreased chemotaxis rate \| aberrant phototaxis
DBS0350596	[act15]: GFP: cepL(763-1114)	cepL	development arrests at loose mound stage \| delayed aggregation \| increased cell-substrate adhesion \| decreased chemotaxis rate \| increased growth rate \| abolished cell polarity \| aberrant phototaxis \| delayed gene expression \| decreased cell size
DBS0350460	[act15]: GFP: docD	docD	increased pseudopod formation \| increased F-actin polymerization \| increased cell motility
DBS0350288	[act15]: GFP: forF(1-1087)	forF	decreased pinocytosis \| decreased phagocytosis \| decreased growth rate
DBS0235662	[act15]: GFP: forH(1-425)	forH	abolished localization to pseudopodium
DBS0304973	[act15]: GFP: gefQ(173-651,818-1298)	gefQ	increased Ras guanyl-nucleotide exchange factor activity
DBS0304971	[act15]: GFP: gefQ(683-833)	gefQ	decreased Ras guanyl-nucleotide exchange factor activity
DBS0304972	[act15]: GFP: gefQ(910-1298)	gefQ	aberrant cytokinesis \| aberrant phototaxis
DBS0350422	[act15]: GFP: gpbB	gpbB	aberrant vegetative growth \| delayed development
DBS0350349	[act15]: GFP: gtaC(1-467: 497-587)	gtaC	abolished localization to nucleus
DBS0350351	[act15]: GFP: gtaC(229-587)	gtaC	abolished localization to cytoplasm
DBS0350359	[act15]: GFP: gtaC(281-467: 497-587)	gtaC	aberrant localization to cytoplasm
DBS0350352	[act15]: GFP: gtaC(281-587)	gtaC	abolished localization to cytoplasm
DBS0350360	[act15]: GFP: gtaC(346-467: 497-587)	gtaC	aberrant cellular localization
DBS0350353	[act15]: GFP: gtaC(346-587)	gtaC	abolished localization to cytoplasm
DBS0350350	[act15]: GFP: gtaC(K469,470,494,496A/ R468,471A)	gtaC	abolished localization to nucleus
DBS0236070	[act15]: GFP: hcpA	hcpA	decreased growth rate \| aberrant anaphase
DBS0237117	[act15]: GFP: krsA	krsA	decreased slug migration
DBS0237118	[act15]: GFP: limE	limE	aberrant cytokinesis
DBS0349983	[act15]: GFP: lmnB	lmnB	aberrant chromatin assembly
DBS0350490	[act15]: GFP: mhcA(T1823D/ T1833D/ T2029D)/ AX3	mhcA	decreased growth rate \| aberrant localization
DBS0350852	[act15]: GFP: nkaP	nkaP	aberrant aggregation \| decreased gene expression \| increased gene expression \| aberrant vegetative growth \| increased chemotaxis rate
DBS0350338	[act15]: GFP: pakA	pakA	increased phagocytosis
DBS0350337	[act15]: GFP: pakA(797-1197)	pakA	decreased phagocytosis \| decreased cell motility
DBS0237122	[act15]: GFP: pats1(2087-2351)	pats1	aberrant cytokinesis
DBS0237123	[act15]: GFP: phg2(1-245)	phg2	decreased phagocytosis
DBS0235442	[act15]: GFP: pldB	pldB	abolished aggregation
DBS0237702	[act15]: GFP: rac1A	rac1A	increased filopodium formation \| increased membrane ruffling
DBS0237703	[act15]: GFP: rac1B	rac1B	increased filopodium formation \| increased membrane ruffling
DBS0237704	[act15]: GFP: rac1C	rac1C	increased filopodium formation \| increased membrane ruffling
DBS0237125	[act15]: GFP: racG(1-168): racH(164-200)	racG \| racH	increased filopodium formation \| decreased chemoattractant-mediated F-actin polymerization \| decreased phagocytosis
DBS0237128	[act15]: GFP: racH(1-163): racG(167-201)	racG \| racH	decreased chemoattractant-mediated F-actin polymerization
DBS0237130	[act15]: GFP: racH(M13V)	racH	increased F-actin polymerization \| aberrant cytokinesis \| aberrant cell morphology
DBS0237132	[act15]: GFP: racH(T18N)	racH	aberrant cytokinesis \| aberrant cell morphology
DBS0237133	[act15]: GFP: racH: gemA(630-658)	gemA \| racH	delayed cytokinesis
DBS0238392	[act15]: GFP: rapA	rapA	increased cell-substrate adhesion
DBS0238393	[act15]: GFP: rapA(G12V)	rapA	increased cell-substrate adhesion
DBS0238394	[act15]: GFP: rapA(S17N)	rapA	decreased cell-substrate adhesion
DBS0237134	[act15]: GFP: sbds	sbds	wild type
DBS0237135	[act15]: GFP: sbds	sbds	wild type
DBS0350715	[act15]: GFP: src1(2-646)	src1	aberrant nuclear envelope morphology
DBS0304563	[act15]: GFP: sun1(283-905)	sun1	increased number of centrosomes \| decreased protein localization to nuclear envelope \| increased cell size \| aberrant nucleus morphology \| aberrant perinuclear space \| aberrant centrosome localization \| aberrant sister chromosome segregation
DBS0350441	[act15]: GFP: talA/ mhcA-/ talA-	mhcA \| talA	aberrant protein localization
DBS0350648	[act15]: HA: Rab14(N121I)	rab14	decreased pinocytosis \| decreased response to hypo-osmotic stress \| aberrant contractile vacuole morphology
DBS0350899	[act15]: HA: rab11(N126I)	rab11A	aberrant contractile vacuole organization and biogenesis \| aberrant contractile vacuole morphology
DBS0350812	[act15]: HA: rab7A(Q67L)	rab7A	increased exocytosis
DBS0350813	[act15]: HA: rab7A(T22N)	rab7A	decreased pinocytosis \| increased secretion of lysosomal enzyme \| decreased exocytosis \| decreased phagocytosis \| abolished macropinocytosis
DBS0238111	[act15]: HA: smkA	smkA	decreased cell polarity \| delayed development \| decreased fruiting body size \| decreased chemotaxis to cAMP
DBS0350429	[act15]: RFP: abpE	abpE-1 \| abpE-2	delayed aggregation
DBS0350867	[act15]: RFP: mtpn	mtpn	increased filopodium formation \| decreased protein localization to cell cortex \| aberrant F-actin organization \| decreased pseudopod size
DBS0237817	[act15]: YFP: wipA	wipA	increased filopodium formation \| increased F-actin polymerization at the leading edge
DBS0237819	[act15]: YFP: wipA(K36A)	wipA	increased filopodium formation \| increased F-actin polymerization at the leading edge
DBS0237821	[act15]: YFP: wipA(K93A/ S95A)	wipA	increased filopodium formation \| increased F-actin polymerization at the leading edge
DBS0350673	[act15]: abpC: GFP	abpC	decreased cell motility
DBS0304574	[act15]: abpD	abpD	abolished protein localization to nuclear envelope
DBS0237096	[act15]: abpE	abpE-1 \| abpE-2	aberrant aggregation \| increased lateral pseudopod formation \| decreased cell motility \| delayed development \| decreased fruiting body size
DBS0350800	[act15]: adprt1A	adprt1A	aberrant cell cycle \| decreased growth rate \| aberrant response to oxidative stress
DBS0238086	[act15]: atg1	atg1	wild type
DBS0238091	[act15]: atg1(1-628)	atg1	wild type
DBS0238088	[act15]: atg1(K36A)	atg1	abolished macroautophagy \| increased number of autophagosomes \| aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0238090	[act15]: atg1(K36A/ 1-628)	atg1	wild type
DBS0350008	[act15]: bzpN: GFP	bzpN	decreased growth rate \| abolished negative regulation of vegetative growth
JK1	[act15]: carA	carA-1 \| carA-2	delayed aggregation
DBS0252737	[act15]: carA(I104A)	carA-1 \| carA-2	decreased cAMP binding
DBS0252732	[act15]: carA(I104C)	carA-1 \| carA-2	decreased protein kinase activation
DBS0252740	[act15]: carA(I104D)	carA-1 \| carA-2	increased cAMP binding \| delayed aggregation \| decreased protein kinase activation \| aberrant cAMP wave formation
DBS0252744	[act15]: carA(I104E)	carA-1 \| carA-2	increased cAMP binding \| delayed aggregation \| aberrant cAMP wave formation
DBS0252741	[act15]: carA(I104F)	carA-1 \| carA-2	increased cAMP binding \| decreased protein kinase activation
DBS0252738	[act15]: carA(I104G)	carA-1 \| carA-2	increased cAMP binding \| decreased protein kinase activation
DBS0252747	[act15]: carA(I104H)	carA-1 \| carA-2	development arrests at loose mound stage \| increased cAMP binding \| decreased protein kinase activation \| abolished cAMP wave formation
DBS0252749	[act15]: carA(I104K)	carA-1 \| carA-2	increased cAMP binding \| decreased protein kinase activation \| abolished aggregation \| abolished cAMP wave formation
DBS0252739	[act15]: carA(I104L)	carA-1 \| carA-2	wild type
DBS0252742	[act15]: carA(I104M)	carA-1 \| carA-2	increased cAMP binding
DBS0252746	[act15]: carA(I104N)	carA-1 \| carA-2	development arrests at loose mound stage \| increased cAMP binding \| decreased protein kinase activation \| abolished cAMP wave formation
DBS0252734	[act15]: carA(I104P)	carA-1 \| carA-2	decreased protein kinase activation
DBS0252745	[act15]: carA(I104Q)	carA-1 \| carA-2	development arrests at loose mound stage \| increased cAMP binding \| decreased protein kinase activation \| abolished cAMP wave formation
DBS0252750	[act15]: carA(I104R)	carA-1 \| carA-2	development arrests at loose mound stage \| increased cAMP binding \| decreased protein kinase activation \| abolished cAMP wave formation
DBS0252743	[act15]: carA(I104S)	carA-1 \| carA-2	increased cAMP binding \| decreased protein kinase activation \| aberrant cAMP wave formation
DBS0252735	[act15]: carA(I104T)	carA-1 \| carA-2	increased cAMP binding \| aberrant cAMP wave formation
DBS0252736	[act15]: carA(I104V)	carA-1 \| carA-2	wild type
DBS0252733	[act15]: carA(I104W)	carA-1 \| carA-2	increased cAMP binding
DBS0252748	[act15]: carA(I104Y)	carA-1 \| carA-2	development arrests at loose mound stage \| increased cAMP binding \| decreased protein kinase activation \| aberrant cAMP wave formation
DBS0302445	[act15]: cfaD	cfaD	decreased growth rate \| aberrant fruiting body morphology
DBS0350333	[act15]: cnrF: GFP	cnrF	aberrant regulation of GTPase activity
DBS0302658	[act15]: cnrN: myc/ smlA-	cnrN \| smlA	decreased fruiting body size
DBS0237102	[act15]: cofA	cofA	increased actin bundle formation \| increased membrane ruffling \| increased cell motility
DBS0350583	[act15]: csaA	csaA	decreased cell-substrate adhesion \| precocious aggregation \| increased calcium-independent cell-cell adhesion
DBS0349864	[act15]: cyrA: GFP	cyrA	increased chemotaxis to cAMP
DBS0237104	[act15]: dagA	dagA	wild type
DBS0237106	[act15]: dhkC(394-661)	dhkC	development arrests at slug stage \| increased slug migration
DBS0235716	[act15]: dhkK	dhkK	precocious aggregation \| development arrests at mound stage
DBS0235705	[act15]: dhkK(D1125N)	dhkK	aberrant cAMP signaling during aggregation \| delayed development
DBS0235707	[act15]: dhkK(H825Q)	dhkK	precocious development \| decreased fruiting body size
DBS0235709	[act15]: dhkK(H825Q/ D1125N)	dhkK	aberrant slug migration \| delayed culmination
DBS0237108	[act15]: fbxA: FLAG	fbxA	decreased prespore cell differentiation
DBS0350365	[act15]: fip(1163-2038)	fip-1 \| fip-2	aberrant prestalk 0 cell differentiation
DBS0350012	[act15]: fps: GFP	fps	increased resistance to bisphosphonate
DBS0235979	[act15]: fszA: GFP	fszA	increased number of tubular mitochondria
DBS0237136	[act15]: gpaA	gpaA	increased stalk length \| aberrant cytokinesis \| aberrant fruiting body morphology
DBS0350680	[act15]: gpaE	gpaE	abolished growth \| decreased chemotaxis to folate
DBS0237145	[act15]: gpaG	gpaG	aberrant fruiting body morphology
DBS0237146	[act15]: gpaH	gpaH	wild type
DBS0350971	[act15]: gpaH/ AX2	gpaH	aberrant cytokinesis \| decreased growth rate \| aberrant spore germination \| increased cell-substrate adhesion \| increased cell-cell adhesion \| aberrant development
DBS0350079	[act15]: grlB	grlB	delayed aggregation
DBS0236152	[act15]: hcpA(1-161: 218-225): GFP	hcpA	decreased growth rate
DBS0252821	[act15]: hssA	hssA	wild type
DBS0350037	[act15]: mekA(299-360)	mekA	decreased aggregate size
DBS0350034	[act15]: mekA(K321A)	mekA	decreased aggregate size
DBS0350033	[act15]: mekA(S444A/ T448A)	mekA	decreased aggregate size
DBS0237203	[act15]: mhkB: FLAG	mhkB	aberrant cytokinesis \| decreased myosin II assembly
DBS0350026	[act15]: mip1/ [act15]: mekA: FLAG	mekA \| mip1-1 \| mip1-2	aberrant protein localization to nucleus
DBS0350331	[act15]: mkpA: GFP: TAP	mkpA	increased resistance to cisplatin
DBS0350330	[act15]: mkpB: GFP: TAP	mkpB-1 \| mkpB-2	increased resistance to cisplatin
DBS0237162	[act15]: myc-cdk8	cdk8	multiple tips \| precocious tip formation
DBS0350050	[act15]: myc: cdk8/ [act15]: FLAG: cycC	cdk8 \| cycC	precocious tip formation
DBS0266837	[act15]: myc: ptpC	ptpC	aberrant signal transduction during aggregation \| aberrant response to hyperosmotic stress \| aberrant protein localization
DBS0350417	[act15]: myc: ptpC	ptpC	aberrant protein phosphorylation
DBS0266839	[act15]: myc: ptpCΔ(C649S)	ptpC	aberrant protein localization to nucleus \| increased protein tyrosine phosphorylation
DBS0266838	[act15]: myc: ptpC(C649S)	ptpC	aberrant protein localization to nucleus \| increased protein tyrosine phosphorylation
DBS0238398	[act15]: myc: rapA	rapA	increased cell-substrate adhesion \| decreased cell motility \| aberrant cell morphology
DBS0238396	[act15]: myc: rapA(G12V)	rapA	increased protein localization to cell cortex \| delayed aggregation \| increased cell-substrate adhesion \| decreased cell motility \| increased protein kinase activation
DBS0238397	[act15]: myc: rapA(S17N)	rapA	decreased cell-substrate adhesion
DBS0237167	[act15]: myc: rckA	rckA	delayed development
DBS0237163	[act15]: myc: rckA(C551A)	rckA	delayed slug formation \| decreased chemotaxis rate
DBS0237164	[act15]: myc: rckA(E510G)	rckA	delayed slug formation \| decreased chemotaxis rate
DBS0237165	[act15]: myc: rckA(E510G/ N511A)	rckA	delayed slug formation \| decreased chemotaxis rate
DBS0237166	[act15]: myc: rckA(K867A)	rckA	delayed slug formation \| precocious aggregation \| decreased chemotaxis rate
DBS0350132	[act15]: myc: splB	splB	increased protein localization to nucleus \| increased protein tyrosine phosphorylation
DBS0349847	[act15]: myoK: Myc	myoK	decreased phagocytosis
DBS0237179	[act15]: myr: rckA	rckA	delayed development \| decreased chemotaxis rate
DBS0349860	[act15]: ndkC	ndkC-1 \| ndkC-2	decreased exocytosis \| decreased pinocytosis \| decreased phagocytosis \| decreased growth rate \| increased growth rate
DBS0237180	[act15]: nramp1: GFP	nramp1	decreased infection rate by a gram-negative pathogenic bacterium \| increased iron ion transport
DBS0350858	[act15]: odc	odc	aberrant cell cycle
DBS0237182	[act15]: pakA	pakA	wild type
DBS0237183	[act15]: pakA(K394A)	pakA	development arrests at mound stage \| delayed development
DBS0237184	[act15]: pakA[CA]	pakA	abolished aggregation
DBS0237185	[act15]: pakA[G+K]	pakA	wild type
DBS0349903	[act15]: pisA	pisA	decreased slug migration \| aberrant tip formation \| delayed aggregation \| decreased fruiting body size
DBS0349902	[act15]: pisA: GFP	pisA	decreased slug migration \| increased gene expression \| decreased gene expression \| delayed aggregation \| delayed development \| decreased phototaxis
DBS0350693	[act15]: pkaC	pkaC	precocious development
DBS0237188	[act15]: pkaC(1-497)	pkaC	precocious development \| decreased intracellular cAMP level \| decreased fruiting body size
DBS0237189	[act15]: pkaR(G135E/ G261A)	pkaR	decreased protein tyrosine phosphorylation \| decreased cAMP binding \| decreased protein kinase activity \| abolished aggregation \| abolished cAMP-induced cAMP pulse
DBS0350701	[act15]: pkaR(G135E/ G261A)/ AX3	pkaR	decreased gene expression \| abolished cAMP-induced cAMP pulse
DBS0350609	[act15]: pkaR(S133T,G135E)	pkaR	decreased cAMP binding \| decreased protein kinase activity \| abolished aggregation \| abolished cAMP-induced cAMP pulse
DBS0350920	[act15]: pkcA	pkcA	increased catalytic activity \| abolished aggregation
DBS0235538	[act15]: pldB	pldB	decreased F-actin polymerization \| increased catalytic activity \| increased exocytosis \| aberrant chemotaxis to cAMP \| abolished aggregation \| decreased sporulation
DBS0349874	[act15]: psaA: GFP	psaA	aberrant sporulation
DBS0350751	[act15]: pten(16-515): GFP	pten	abolished catalytic activity
DBS0350750	[act15]: pten(186-515): GFP	pten	abolished catalytic activity
DBS0350752	[act15]: pten(C124S): GFP	pten	abolished catalytic activity
DBS0350753	[act15]: pten(G129E): GFP	pten	abolished catalytic activity
DBS0350318	[act15]: rab11A: RFP	rab11A	aberrant contractile vacuole organization and biogenesis \| abolished response to hypo-osmotic stress \| decreased contractile vacuole size
DBS0350951	[act15]: rac1B(Q61L)	rac1B	aberrant F-actin organization \| increased lateral pseudopod formation \| decreased chemotaxis to cAMP
DBS0350952	[act15]: rac1B(T17N)	rac1B	aberrant F-actin organization \| delayed aggregation \| abolished cell polarity \| abolished chemotaxis to cAMP
DBS0350469	[act15]: racE(G20V): GFP	racE	decreased F-actin polymerization \| aberrant cytokinesis \| decreased growth rate
DBS0350262	[act15]: rbg3	rbg3	increased lysosome size \| decreased growth rate \| delayed development
DBS0237192	[act15]: rblA	rblA	increased cell cycle length
DBS0349938	[act15]: rgaA	rgaA	aberrant cytokinesis \| decreased cell motility \| decreased basal F-actin level
DBS0350294	[act15]: rheb: YFP	rheb	increased cell size
DBS0350890	[act15]: rnp1A	rnp1A	increased resistance to nocodazole
DBS0350575	[act15]: rps4	rps4	aberrant aggregation \| decreased spore viability \| aberrant actin cytoskeleton organization \| aberrant vegetative growth \| aberrant fruiting body morphology
DBS0236915	[act15]: rzpA	rzpA	increased gene expression \| decreased gene expression \| delayed culmination
DBS0349793	[act15]: sadA(921-952)	sadA	decreased cell-substrate adhesion
SA604	[act15]: sgkA: FLAG	sgkA	increased resistance to cisplatin \| aberrant cytokinesis \| increased resistance to carboplatin
DBS0238735	[act15]: snfA(1-379): GFP	snfA	increased stalk width \| increased intracellular ATP level \| decreased growth rate \| increased number of mitochondria \| decreased phototaxis \| decreased stalk length \| aberrant mitochondrion organization
DBS0350976	[act15]: snfA: YFP	snfA	decreased growth rate \| aberrant fruiting body morphology
DBS0304457	[act15]: sodA/ gcsA-	gcsA \| sodA	wild type
DBS0237194	[act15]: sodA: myc	sodA	decreased gene expression \| abolished aggregation
DBS0237195	[act15]: spkA: FLAG	spkA-1 \| spkA-2	aberrant aggregation \| decreased cell polarity \| aberrant F-actin organization \| decreased chemotaxis rate
AK1209	[act15]: tagA(1-890)	tagA	multiple tips in mound
DBS0350962	[act15]: tor(212-2380): YFP	tor	decreased growth rate \| aberrant development
DBS0237198	[act15]: torA	torA	abolished growth
DBS0350862	[act15]: tpt1: YFP	tpt1	decreased growth rate
DBS0237199	[act15]: trrA	trrA	aberrant aggregation \| decreased growth rate \| decreased phagocytosis \| delayed culmination
DBS0237200	[act15]: vasP	vasP	increased filopodium formation \| increased basal F-actin level
DBS0350911	[act6]: GFP: cepA/ cepA(183-346)	cepA	increased number of centrosomes
DBS0349984	[act6]: GFP: lmnB(1-712)	lmnB	abolished growth \| increased sensitivity to fluid shear stress
DBS0350497	[act6]: GFP: rab2A	rab2A	aberrant response to hypo-osmotic stress \| decreased phagocytosis \| increased growth rate
DBS0350499	[act6]: GFP: rab2A(Q64L)	rab2A	decreased autophagic cell death \| aberrant response to hypo-osmotic stress \| aberrant cell-cell adhesion \| increased growth rate \| increased phagocytosis
DBS0306243	[act6]: GFP: sun1	sun1	increased number of centrosomes \| aberrant nucleus morphology \| aberrant sister chromosome segregation \| aberrant centromere complex assembly \| aberrant centrosome organization
DBS0306244	[act6]: GFP: sun1(1-722)	sun1	increased number of centrosomes \| aberrant nucleus morphology \| aberrant sister chromosome segregation \| aberrant centromere complex assembly \| aberrant centrosome organization
DBS0350685	[act6]: csaA	csaA	increased slug size \| increased calcium-independent cell-cell adhesion
DBS0237205	[act6]: dia1	dia1	delayed aggregation
DBS0236905	[act6]: mrps4	mrps4	precocious aggregation
DBS0235444	[act6]: myc: eppA(S250A)	eppA	decreased growth rate \| delayed development \| decreased intracellular cAMP level
DBS0235445	[act6]: myc: eppA(S325A)	eppA	decreased growth rate
DBS0266836	[act6]: ptpB	ptpB	delayed aggregation \| decreased fruiting body size
DBS0350807	[act6]: rabS(N137I): GFP	rabS	aberrant response to hyperosmotic stress \| aberrant response to hypo-osmotic stress
DBS0350806	[act6]: rabS: GFP	rabS	aberrant response to hyperosmotic stress
DBS0304410	[act6]: srsA	srsA	increased aggregate size \| decreased gene expression \| increased slug size \| delayed aggregation \| decreased sporulation \| aberrant fruiting body morphology
DBS0237220	[act6]: trap1	trap1	development arrests at loose mound stage \| aberrant aggregation \| abolished pinocytosis \| increased gene expression \| decreased gene expression \| decreased growth rate
DBS0350695	[act6]: yakA	yakA	increased gene expression \| abolished growth
DBS0350069	[act6]: zizB: GFP	zizB	aberrant cell separation during cytokinesis \| increased filopodium formation
DBS0304460	[act]: alrA/ gcsA-	alrA \| gcsA	wild type
DBS0349955	[ampA]: RFP: ampA	ampA	development arrests at mound stage
DBS0350705	[cotC]: pkaC	pkaC	precocious development \| aberrant development \| aberrant fruiting body morphology
DBS0350706	[cotC]: pkaC/ [spiA]: lacZ	pkaC \| spiA	precocious gene expression
DBS0350048	[cycC]: cycC: TAP	cycC	decreased protein level
DBS0305081	[dscB]: GFP: vamp7A(L35A)	vamp7A	increased localization to plasma membrane
DBS0350820	[dscB]: cafA	cafA	increased gene expression \| precocious development
DBS0237237	[dscB]: cycB(106-436)	cycB	cell cycle arrest
DBS0350922	[dscB]: dicA(1-278)	dicA	increased cell death \| abolished protein binding \| aberrant microtubule cytoskeleton organization \| aberrant Golgi localization \| aberrant sister chromosome segregation \| aberrant centrosome organization
DBS0350923	[dscB]: dicA(48-654)	dicA	aberrant microtubule cytoskeleton organization \| aberrant Golgi localization \| decreased protein binding \| aberrant sister chromosome segregation \| aberrant centrosome organization
DBS0350589	[dscB]: rapA	rapA	decreased pinocytosis \| aberrant F-actin organization \| aberrant cell morphology \| increased phagocytosis
DBS0350590	[dscB]: rapA(G12T)	rapA	decreased pinocytosis \| increased phagocytosis
DBS0350933	[dscC]: kif2	kif2	aberrant cell cycle
DBS0350703	[ecmA]: pkaC	pkaC	abolished tip formation \| development arrests at mound stage
DBS0350659	[ecmA]: pkaC(9-648)	pkaC	development arrests at tipped mound stage
DBS0350699	[ecmA]: pkaR(G135E/ G261A)	pkaR	decreased slug size \| aberrant culminant morphology \| delayed tip formation \| aberrant slug migration \| increased slug migration \| aberrant prestalk cell differentiation
DBS0350700	[ecmA]: pkaR(G135E/ G261A)/ [ecmB-frag]: lacZ	pkaR	abolished stalk cell differentiation
DBS0350704	[ecmB]: pkaC	pkaC	abolished tip formation \| development arrests at mound stage
DBS0350639	[ecmF]: expl3: myc	expl3	aberrant stalk morphogenesis \| delayed slug formation
DBS0304865	[expl7]: expl7: GFP	expl7	aberrant culminant morphology
DBS0237252	[gpaA]: gpaA(G45V)	gpaA	delayed development
DBS0237253	[gpaA]: gpaA(Q206L)	gpaA	increased basal disc size
DBS0349948	[ndm]: ndm: RFP	ndm	development arrests at mound stage
DBS0236086	[pdsA-agg]: pdsA	pdsA	precocious development
DBS0236111	[pdsA-ldev]: pdsA	pdsA	development arrests at mound stage
DBS0236484	[pkaC]: pkaC	pkaC	increased gene expression \| abolished SDF-2 production \| decreased intracellular cAMP level \| precocious development \| precocious gene expression \| aberrant fruiting body morphology
DBS0350709	[pkaC]: pkaC/ [dscC]: lacZ	dscC-1 \| dscC-2 \| pkaC	aberrant gene expression
DBS0350696	[pkaC]: pkaC/ srfA-	pkaC \| srfA	aberrant spore coat morphology \| aberrant gene expression
DBS0237289	[psmC1]: psmC1	psmC1	aberrant cytokinesis \| delayed tip formation \| delayed gene expression
DBS0350658	[pspA]: pkaC(9-648)	pkaC	precocious sporulation \| aberrant fruiting body morphology
DBS0350697	[pspA]: pkaR(G135E/ G261A)	pkaR	abolished gene expression \| decreased gene expression \| translucent sorus
DBS0237290	[ptpA1]: ptpA1	ptpA1-1 \| ptpA1-2	delayed aggregation \| decreased growth rate \| aberrant fruiting body morphology
DBS0304911	[tre]: paxB	paxB	abolished sporulation \| aberrant endocytosis \| decreased cell-substrate adhesion \| aberrant chemotaxis to folate \| development arrests at mound stage \| decreased cell motility \| increased cell-cell adhesion
DBS0350267	[tre]: secG	secG	increased filopodium formation \| aberrant F-actin polymerization \| development arrests at mound stage \| aberrant actin cytoskeleton organization \| abolished cell polarity \| abolished chemotaxis to cAMP \| delayed gene expression
DBS0350726	[unk]: GFP: cepE	cepE	increased number of centrosomes \| aberrant cytokinesis
DBS0350447	[unk]: PTEN(H385G/ N389A/ H390A)	pten	decreased localization to plasma membrane \| decreased fruiting body size
DBS0350716	[unk]: pdsA	pdsA	aberrant development
DBS0350259	[unk]: pikA(1-492(S7A/ S11A/ S109A/ S113A/ S177A/ S181A))	pikA	aberrant localization to plasma membrane
DBS0350837	[unk]: rasD(G12T)/ [rasD]: rapA	rapA \| rasD	aberrant culmination \| decreased prespore cell differentiation \| aberrant gene expression \| decreased stalk cell differentiation \| multiple tips in mound
DBS0350464	[unk]: vasP(1-197: 221-261: 285-380)	vasP	abolished F-actin polymerization
DBS0350463	[unk]: vasP(1-261: 285-380)	vasP	aberrant F-actin organization
DBS0350465	[unk]: vasP(1-340: 376-380)	vasP	decreased F-actin polymerization \| aberrant F-actin organization
DBS0349920	aarA-/ [act15]: GFP-mhcA	aarA	aberrant stalk morphogenesis \| aberrant protein localization
DBS0237938	abpC-/ [act15]: GFP: abpC(9-148)	abpC	aberrant phototaxis
DBS0235426	abpC-/ [act15]: abpC	abpC	wild type
DBS0350938	abpC-/ [act15]: abpC	abpC	wild type
DBS0237945	abpC-/ [act15]: abpC(1-348: 449-857): GFP	abpC	aberrant F-actin organization \| aberrant phototaxis
DBS0237946	abpC-/ [act15]: abpC(1-556: 644-857): GFP	abpC	aberrant F-actin organization \| aberrant phototaxis
DBS0237941	abpC-/ [act15]: abpC(1-739): GFP	abpC	aberrant phototaxis
DBS0349852	abpE-/ [act15]: abpE	abpE-1 \| abpE-2	decreased phagocytosis
DBS0350720	acaA-/ [acaA-agg]: acaA: myc	acaA	wild type \| decreased gene expression \| decreased fruiting body size
DBS0350721	acaA-/ [acaA-psp]: acaA: myc	acaA	decreased gene expression \| decreased aggregate size \| decreased fruiting body size
DBS0350722	acaA-/ [acaA-pst]: acaA: myc	acaA	wild type
DBS0350702	acaA-/ [act15]: HA: pkaC	acaA \| pkaC	wild type \| delayed development \| decreased intracellular cAMP level
DBS0350725	acaA-/ [act15]: HA: pkaC/ acrA-	acaA \| acrA \| pkaC	decreased gene expression \| abolished adenylate cyclase activity \| development arrests at tipped mound stage
DBS0350737	acaA-/ [act15]: acaA	acaA	aberrant slug formation
DBS0350738	acaA-/ [act15]: acaA(1-390;398-1407)	acaA	abolished aggregation
DBS0350739	acaA-/ [act15]: acaA(L394T/ K482N)	acaA	wild type
DBS0350735	acaA-/ [act15]: pkaR(G135E/ G261A)	acaA \| pkaR	increased intracellular cAMP level
DBS0350736	acaA-/ [unk]: acaA(F306L/ S498G,K504E,E593V,I649T)	acaA	abolished cAMP wave formation
DBS0350734	acaA-/ [unk]: acaA(N333D,G633S)	acaA	abolished adenylate cyclase activity
DBS0350733	acaA-/ [unk]: acaA(V427I,S642F)	acaA	abolished activation of adenylate cyclase
DBS0350711	acaA-/ [unk]: acgA	acaA \| acgA	aberrant development
DBS0350055	acapA-/ [act15]: acapA(R633Q): GFP	acapA	aberrant filopodium formation \| aberrant post-lysosome organization and biogenesis
DBS0350054	acapA-/ [act15]: acapA: GFP	acapA	increased filopodium formation
DBS0350723	acrA-/ [act15]: acaA(L394S)	acaA \| acrA	wild type
DBS0237786	acrA-/ [act15]: acgA(1-401)	acgA \| acrA	decreased gene expression \| decreased prespore cell differentiation \| decreased sporulation
DBS0350724	acrA-/ [pkaC]: pkaC	acrA \| pkaC	decreased spore viability \| decreased fruiting body size \| precocious development
DBS0235473	alrA-/ [act15]: alrA	alrA	wild type
DBS0235488	alxA-/ [act15]: FLAG: alxA	alxA	delayed development
DBS0235476	alxA-/ [act15]: alxA(1-596): myc2	alxA	wild type
DBS0235477	alxA-/ [act15]: alxA(1-697): myc2	alxA	wild type
DBS0235478	alxA-/ [act15]: alxA(155-697): myc2	alxA	aberrant fruiting body morphology
DBS0235479	alxA-/ [act15]: alxA(293-697): myc2	alxA	aberrant fruiting body morphology
DBS0235480	alxA-/ [act15]: alxA(460-794): myc2	alxA	aberrant fruiting body morphology
DBS0235481	alxA-/ [act15]: alxA(D310A/ N311A)	alxA	wild type
DBS0235482	alxA-/ [act15]: alxA(Q181E/ Q183)	alxA	wild type
DBS0235483	alxA-/ [act15]: alxA(S700A/ S704A/ S708A)	alxA	wild type
DBS0235484	alxA-/ [act15]: alxA(S700D/ S704D/ S708D)	alxA	wild type
DBS0235485	alxA-/ [act15]: alxA(Y315D)	alxA	wild type
DBS0235486	alxA-/ [act15]: alxA(Y315F)	alxA	wild type
DBS0235487	alxA-/ [act15]: alxA: myc2	alxA	wild type
DBS0349953	ampA/ [ampA]: TAP	ampA	increased protein secretion \| development arrests at mound stage
DBS0235495	ampA/ [ampA]: ampA	ampA	increased pseudopod formation \| decreased cell-substrate adhesion \| increased pinocytosis \| increased F-actin polymerization \| aberrant chemotaxis to folate
DBS0349952	ampA/ [ampA]: ampA/ lmbd2B-	ampA \| lmbd2B	aberrant chemotaxis
DBS0235501	amtC-/ [act15]: cudA	amtC \| cudA	delayed culmination
DBS0235502	amtC-/ [ecmA]: cudA	amtC \| cudA	delayed culmination
DBS0235503	amtC-/ [pspA]: cudA	amtC \| cudA	development arrests at slug stage
DBS0305085	apm2-/ [dscB]: GFP: vamp7A	apm2 \| vamp7A	increased protein localization to plasma membrane
DBS0305083	apm3-/ [dscB]: GFP: vamp7A	apm3 \| vamp7A	increased protein localization to plasma membrane
DBS0235510	aprA-/ [act15]: aprA	aprA	decreased growth rate \| aberrant fruiting body morphology
DBS0350009	aprA-/ [act15]: bzpN: GFP	aprA \| bzpN	abolished negative regulation of vegetative growth
DBS0238085	atg1-/ [act15]: atg1	atg1	wild type
DBS0238092	atg1-/ [act15]: atg1(1-628)	atg1	aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0238087	atg1-/ [act15]: atg1(K36A)	atg1	aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0238089	atg1-/ [act15]: atg1(K36A/ 1-628)	atg1	aberrant cellular response to nitrogen starvation \| abolished aggregation
DBS0305978	atg9-/ [act15]: GFP: atg9	atg9	wild type
DBS0305979	atg9-/ [act15]: atg9: GFP	atg9	wild type
DBS0350568	carA-/ carC-/ [act15]: carA(261-359;S299A,S302G,S303G,S304G,S308A,S324G,S325A,S331A)(369-392;S383A,S385A)	carA-1 \| carA-2 \| carC	aberrant F-actin polymerization \| aberrant adaptation of adenylate cyclase \| aberrant chemotaxis to cAMP \| abolished streaming \| aberrant cAMP wave formation
DBS0350436	cdk8-/ [act15]: myc: cdk8	cdk8	wild type
DBS0350437	cdk8-/ [act15]: myc: cdk8(D194A)	cdk8	decreased spore viability \| abolished aggregation
DBS0306227	cenB-/ [act15]: RFP: cenB	cenB	wild type
DBS0350010	cfaD-/ [act15]: bzpN: GFP	bzpN \| cfaD	abolished negative regulation of vegetative growth
DBS0302446	cfaD-/ [act15]: cfaD	cfaD	wild type
DBS0350090	chcA-/ [act15]: GFP: ap2a1	ap2a1-1 \| ap2a1-2 \| chcA	aberrant protein localization
DBS0302455	chcA-/ [act15]: epnA: GFP	chcA \| epnA	aberrant protein localization to coated pits
DBS0350091	chcA-/ [act15]: gppA: GFP	chcA \| gppA	aberrant protein localization to plasma membrane
DBS0235604	clc-/ [act15]: GFP-clc(146-194)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphology
DBS0235605	clc-/ [act15]: GFP-clc(85-124)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphology
DBS0235607	clc-/ [act15]GFP: clc(1-124)	clc	abolished cytokinesis \| wild type \| aberrant fruiting body morphology
DBS0350474	cln3-/ [act15]: GFP: cln3	cln3	wild type
DBS0350309	cnrF-/ [act15]: cnrF: RFP	cnrF	wild type
DBS0302656	cnrN-/ [act15]: cnrN	cnrN	wild type
DBS0350345	corA-/ [act15]: GFP: mhkA	corA \| mhkA	wild type
DBS0350346	corA-/ [act15]: GFP: mhkB	corA \| mhkB	wild type
DBS0350344	corA-/ [act15]: GFP: mhkC	corA \| mhkC	decreased catalytic activity \| wild type
DBS0350343	corA-/ [act15]: GFP: pakA(797-1197)	corA \| pakA	wild type
DBS0350371	corA-/ [act15]: corA	corA	wild type
DBS0238320	cpnA-/ [act15]: GFP: cpnA	cpnA	delayed response to hypo-osmotic stress \| decreased culmination \| delayed development
DBS0349922	ctxA-/ [act15]: GFP-mhcA	ctxA	aberrant stalk morphogenesis \| aberrant tip formation \| aberrant protein localization
DBS0350293	ctxA-/ ctxB-/ [act15]: GFP: arcA	arcA \| ctxA \| ctxB	aberrant protein localization to cell cortex
DBS0349972	ctxA-/ ctxB-/ [act15]: acaA: YFP	acaA \| ctxA \| ctxB	aberrant fruiting body morphology
DBS0349973	ctxA-/ ctxB-/ [act15]: carA: YFP	carA-1 \| carA-2 \| ctxA \| ctxB	abolished adenylate cyclase activity \| abolished culmination \| abolished streaming
DBS0266761	culB-/ [act15]: pkaC	culB \| pkaC	abolished gene expression \| abolished sporulation \| precocious gene expression \| abolished aggregation
DBS0349807	detA-/ [act6]: GFP: detA	detA	wild type
DBS0349816	detA-/ [act6]: GFP: detA/ [act6]: 3xHA: culD	culD \| detA	increased gene expression
DBS0349817	detA-/ [act6]: GFP: detA/ [act6]: 3xHA: repE	detA \| repE	increased gene expression
DBS0349813	detA-/ [cotB]: GFP	detA	decreased prespore cell differentiation
DBS0349811	detA-/ [ecm0]: lacZ	detA	aberrant prestalk 0 cell differentiation
DBS0349812	detA-/ [ecmA0]: GFP	detA	increased prestalk cell differentiation
DBS0349808	detA-/ [ecmA0]: lacZ	detA	increased prestalk cell differentiation
DBS0349809	detA-/ [ecmA]: lacZ	detA	increased prestalk A cell differentiation
DBS0349810	detA-/ [ecmB]: lacZ	detA	delayed development
DBS0235703	dhkA-/ [pkaC]: pkaC	dhkA \| pkaC	aberrant stalk morphogenesis
DBS0235712	dhkK-/ [act15]: dhkK(D1125N)	dhkK	aberrant fruiting body morphology
DBS0235719	dia1-/ [act6]: trap1	dia1 \| trap1	aberrant aggregation \| decreased fruiting body size
DBS0235903	dimB-/ [act15]: dimA: GFP	dimA \| dimB	abolished protein localization to nucleus
DBS0235904	dimB-/ [act15]: dimB: GFP	dimB	wild type
DBS0349975	dmtA-/ [dimB]: dimB	dimB \| dmtA	decreased prestalk B cell differentiation
DBS0238511	drkC-/ [act15]: drkC(1-497): YFP	drkC	decreased phagocytosis
DBS0238513	drkC-/ [act15]: drkC(K518R): YFP	drkC	decreased phagocytosis
DBS0350218	drnB-/ [act15]: pre-miRNA	drnB	abolished microRNA processing
DBS0350210	drnB-/ [act6]: lacZ/ [RNAi]lacZ	drnB	abolished production of siRNA involved in RNA interference \| abolished transitive RNA interference
DBS0302602	dsgg-/ OE]: dsgg(Delta-Fbox)	dsgg	wild type
DBS0302606	dsgg-/ [OE]: GFP: lvsD	dsgg \| lvsD	wild type
DBS0302599	dsgg-/ [OE]: dsgg	dsgg	wild type
DBS0302601	dsgg-/ [OE]: dsgg(Q551A)	dsgg	aberrant contractile vacuole organization and biogenesis
DBS0302600	dsgg-/ [OE]: dsggR515A)	dsgg	aberrant contractile vacuole organization and biogenesis
DBS0302607	dsgg-/ [OE]: lvsA	dsgg \| lvsA	aberrant contractile vacuole organization and biogenesis
DBS0302611	dsgg-/ [OE]: phgA	dsgg \| phgA	aberrant contractile vacuole organization and biogenesis
DBS0302678	dsgg-/ [OE]: rab8A	dsgg \| rab8A	aberrant contractile vacuole organization and biogenesis
DBS0238237	dstA-/ GFP: dstA(237-707): ORF+	dstA	abolished culmination \| decreased stalk length
DBS0252824	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 2C	2C \| dstA	aberrant fruiting body morphology
DBS0252823	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: 7E	7E \| dstA \| hssB	wild type
DBS0252826	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0276165	DDB_G0276165 \| dstA	aberrant fruiting body morphology
DBS0252825	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: DDB_G0282325	DDB_G0282325 \| dstA	aberrant fruiting body morphology
DBS0252816	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: hssA	dstA \| hssA	wild type
DBS0252822	dstA-/ GFP: dstA(237-707): ORF+/ [act15]: hssB	dstA \| hssB	wild type
DBS0350804	ehd-/ [act15]: dymA: GFP	dymA \| ehd	aberrant phagosome maturation \| decreased phagosomal proteolysis
DBS0302598	elmoA-/ [act15]: elmoA(1-903/ 959-977): GFP	elmoA	decreased cell motility \| increased phagocytosis
DBS0302591	elmoA-/ [act15]: elmoA: GFP	elmoA	wild type
DBS0302457	epnA-/ [act15]: GFP: epnA(253-677)	epnA	aberrant spore morphology \| abolished localization to coated pits \| abolished localization to plasma membrane
DBS0302456	epnA-/ [act15]: epnA(1-133): GFP	epnA	aberrant localization to coated pits
DBS0302474	epnA-/ [act15]: epnA(R65A/ K78A): GFP	epnA	aberrant spore morphology \| abolished localization to coated pits \| abolished localization to plasma membrane \| abolished phosphatidylinositol-4,5-bisphosphate binding
DBS0302475	epnA-/ [act15]: epnA(T107A): GFP	epnA	aberrant spore morphology
DBS0302454	epnA-/ [act15]: epnA: GFP	epnA	wild type
DBS0235948	eppA-/ [act6]: myc: eppA	eppA	wild type
DBS0350681	erkA-/ [act15]: gpaE	erkA \| gpaE	wild type
DBS0304905	forC-/ [act15]: GFP: forC	forC	wild type
DBS0235971	forH-/ [act15]: GFP: forH	forH	increased filopodium formation \| decreased cell motility \| increased cell-substrate adhesion
DBS0304440	frmA-/ [unk]: GFP	frmA	decreased gene expression \| increased cell-cell adhesion \| delayed development \| aberrant development \| abolished phototaxis
DBS0305026	gabT-[pkaC]: pkaC	gabT \| pkaC	aberrant protein secretion
DBS0304912	gbpC-/ [act15]: gbpC	gbpC	wild type
DBS0304917	gbpC-/ [act15]: gbpC(1-1698: 2005-2631)	gbpC	decreased chemotaxis to cAMP
DBS0349868	gbpC-/ [act15]: gbpC(1-2331: 2470-2631): GFP	gbpC	aberrant streaming \| decreased chemotaxis to cAMP
DBS0304918	gbpC-/ [act15]: gbpC(311-2631)	gbpC	decreased chemotaxis to cAMP
DBS0304916	gbpC-/ [act15]: gbpC(F1892A)	gbpC	decreased chemotaxis to cAMP
DBS0304915	gbpC-/ [act15]: gbpC(F2082A/ E2084A/ F2564A/ E2566A)	gbpC	decreased chemotaxis to cAMP
DBS0304913	gbpC-/ [act15]: gbpC(K342N)	gbpC	decreased chemotaxis to cAMP
DBS0304914	gbpC-/ [act15]: gbpC(K905W)	gbpC	decreased chemotaxis to cAMP
DBS0235998	gbpD-/ [act15]: gbpD	gbpD	aberrant F-actin organization \| increased cell-substrate adhesion \| increased lateral pseudopod formation \| decreased chemotaxis rate \| abolished aggregation
DBS0350387	gcsA-/ [act15]: carA	carA-1 \| carA-2 \| gcsA	aberrant initiation of development
DBS0350388	gcsA-/ [act15]: yakA	gcsA \| yakA	wild type
DBS0237190	gdt1-/ [act15]: pkaR(G135E/ G261A)	gdt1 \| pkaR	increased gene expression \| abolished aggregation
DBS0350449	gefA-/ dscB]: rasG(S17N)	gefA \| rasG	decreased chemoattractant-mediated F-actin polymerization \| decreased positive regulation of GTPase activity \| aberrant chemotaxis to cAMP \| decreased protein kinase activation
DBS0304985	gefQ-/ [act15]: GFP: gefQ(172-654)	gefQ	abolished Ras guanyl-nucleotide exchange factor activity \| decreased phototaxis
DBS0304986	gefQ-/ [act15]: GFP: gefQ(910-1298)	gefQ	decreased phototaxis
DBS0238390	gnt15-/ [act15]: FLAG: gnt15	gnt15	wild type
DBS0238391	gnt15-/ [act15]: FLAG: gnt15	gnt15	wild type
DBS0236092	gpaA-/ [gpaA]: gpaA(G45V)	gpaA	delayed development
DBS0236093	gpaA-/ [gpaA]: gpaA(Q206L)	gpaA	increased basal disc size
DBS0236096	gpaB-/ [act15]: gpaB	gpaB	abolished aggregation
DBS0266942	gpaB-/ [act15]: gpaB	gpaB	delayed aggregation
DBS0266939	gpaB-/ [act15]: gpaB(1-345): gpaD(337-345)	gpaB \| gpaD	abolished aggregation
DBS0237137	gpaB-/ [act15]: gpaB(D154V)	gpaB	aberrant aggregation \| decreased cAMP-induced cGMP pulse \| decreased activation of adenylate cyclase \| decreased chemotaxis rate \| decreased cAMP-induced cAMP pulse
DBS0237138	gpaB-/ [act15]: gpaB(E190G)	gpaB	aberrant aggregation \| decreased cAMP-induced cGMP pulse \| decreased activation of adenylate cyclase \| decreased cAMP-induced cAMP pulse
DBS0237139	gpaB-/ [act15]: gpaB(I104S)	gpaB	aberrant aggregation \| decreased cAMP-induced cGMP pulse \| decreased activation of adenylate cyclase \| decreased chemotaxis rate \| decreased cAMP-induced cAMP pulse
DBS0237140	gpaB-/ [act15]: gpaB(L110S)	gpaB	aberrant aggregation \| decreased cAMP-induced cGMP pulse \| decreased activation of adenylate cyclase \| decreased chemotaxis rate \| decreased cAMP-induced cAMP pulse
DBS0237141	gpaB-/ [act15]: gpaB(L76P)	gpaB	abolished aggregation
DBS0237142	gpaB-/ [act15]: gpaB(N74D)	gpaB	decreased cAMP-induced cGMP pulse \| decreased activation of adenylate cyclase \| decreased chemotaxis rate \| abolished aggregation \| decreased cAMP-induced cAMP pulse
DBS0237143	gpaB-/ [act15]: gpaB(R64G)	gpaB	decreased chemotaxis rate \| abolished aggregation
DBS0237144	gpaB-/ [act15]: gpaB(S155P)	gpaB	decreased chemotaxis rate \| abolished aggregation
DBS0236097	gpaB-/ [gpaA]: gpaB	gpaB	abolished aggregation
DBS0236099	gpaB-/ [gpaB]: gpaB	gpaB	wild type
DBS0266944	gpaD-/ [act15]: gpaB	gpaB \| gpaD	decreased accumulation of cGMP \| decreased chemotaxis to folate \| aberrant fruiting body morphology
DBS0266946	gpaD-/ [act15]: gpaB(1-345): gpaD(337-345)	gpaB \| gpaD	decreased accumulation of cGMP \| aberrant fruiting body morphology
DBS0266943	gpaD-/ [act15]: gpaD	gpaD	wild type
DBS0266945	gpaD-/ [act15]: gpaE	gpaD \| gpaE	decreased accumulation of cGMP \| decreased chemotaxis to folate \| aberrant fruiting body morphology
DBS0266947	gpaD-/ [act15]: gpaE(1-339): gpaD(337-345)	gpaD \| gpaE	decreased accumulation of cGMP \| decreased chemotaxis to folate \| aberrant fruiting body morphology
DBS0266941	gpaE-/ [act15]: gpaE	gpaE	precocious tip formation
DBS0266948	gpaE-/ [act15]: gpaE(1-339): gpaD(337-345)	gpaD \| gpaE	precocious tip formation
DBS0350678	gpaE-/ [act15]: gpaE(K10E/ K11E)	gpaE	delayed tip formation \| delayed gene expression
LW14	gpbA-/ [OE]: carA	carA-1 \| carA-2 \| gpbA	decreased protein kinase activation
DBS0350470	gpbA-/ [act15]: GFP: cap	cap \| gpbA	decreased phagocytosis
HO547	gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: CFP: FKBP/ [act15]: limE(1-145): GFP	gpbA	aberrant cortical actin cytoskeleton organization
HO543	gpbA-/ [act6]: FRB: [act15]: RFP: gpbA/ [act15]: cnxA: YFP: FKBP	gpbA	abolished chemotaxis to folate \| decreased electrotaxis
DBS0350479	gpr89-/ [act15]: gpr89: GFP	gpr89	wild type
DBS0304815	grlA-/ [act15]: grlA: GFP	grlA	aberrant tip formation
DBS0238866	grlJ-/ [act15]: grlJ: GFP	grlJ	wild type
DBS0350284	grlJ-/ [act15]: grlJ: GFP	grlJ	wild type
DBS0238687	grpA-/ [act15]: grpA-FLAG	grpA	wild type
DBS0349930	gskA-/ [act15]: GFP: tacA	gskA \| tacA	increased protein localization to nucleus
DBS0349881	gskA-/ [act15]: gskA(Y214F)	gskA	abolished streaming
DBS0350260	gskA-/ [unk]: pikA(1-492(S7D/ S11D/ S109D/ S113D/ S177D/ S181D))	gskA \| pikA	wild type
DBS0350348	gtaC-/ [act15]: GFP: gtaC	gtaC	wild type
DBS0350357	gtaC-/ [act15]: GFP: gtaC(C500,503,522,525S)	gtaC	aberrant gene expression \| abolished aggregation \| decreased fruiting body size
DBS0350358	gtaC-/ [act15]: GFP: gtaC(T376A/ S379,380A/ C500,503,522,525S)	gtaC	aberrant localization to nucleus
DBS0350361	gtaC-/ [act15]: gtaC: (468-496): GFP: gtaC	gtaC	development arrests at mound stage \| decreased aggregate size \| precocious development
DBS0350257	gxcC-/ [act15]: GFP: gxcC	gxcC	wild type
DBS0350269	gxcT-/ [act15]: GFP: gxcT	gxcT	wild type
DBS0350656	hatA-/ [hatB]: hatB	hatA \| hatB	aberrant cellular response to stress
DBS0350289	hspc300-/ [act15]: myc: hspc300	hspc300	wild type
DBS0252702	icmA-/ [act15]: TAP: YFP: rasG	icmA-1 \| icmA-2 \| rasG	abolished C-terminal protein amino acid methylation
DBS0238521	icpA-/ [act15]: GFP: icpA(1-1013)	icpA	aberrant protein localization
DBS0350439	iplA-/ [act15]: GFP: iplA	iplA	wild type
DBS0350959	kif10-/ [act15]: dhcA(1384-4725)	dhcA \| kif10	wild type
DBS0350022	kif5-/ [act15]: FLAG: kif5	kif5	aberrant cytokinesis \| aberrant cell morphology
DBS0350023	kif5-/ [act15]: FLAG: kif5(342-990)	kif5	aberrant cell morphology
DBS0350024	kif5-/ [act15]: GFP: kif5(805-990)	kif5	aberrant cytokinesis
DBS0350947	kif8-/ [act15]: dhcA(1384-4725)	dhcA \| kif8	wild type
DBS0350044	kil2-/ [act15]: kil1	kil1 \| kil2	abolished resistance to a pathogenic bacterium
DBS0236493	krsA-/ [act15]: GFP: krsA	krsA	wild type
DBS0238721	krsA-/ [act15]: GFP: krsA	krsA	wild type
DBS0238722	krsA-/ [act15]: GFP: krsA(K49R)	krsA	aberrant streaming
DBS0238723	krsA-/ [act15]: GFP: krsA(T173A)	krsA	abolished streaming
DBS0238725	krsA-/ [act15]: GFP: krsA(deltaC)	krsA	aberrant streaming
DBS0238724	krsA-/ [act15]: GFP: krsA(deltaKinase)	krsA	abolished streaming
DBS0238726	krsA-/ [act15]: GFP: krsA(deltaNS)	krsA	abolished streaming
DBS0350537	ku80-/ myc: ku80(1-782)	ku80	decreased DNA mediated transformation
DBS0350453	lpten-/ [act15]: lpten: RFP	lpten	wild type
DBS0350036	mekA-/ [act15]: mekA(299-360)	mekA	decreased aggregate size
DBS0350035	mekA-/ [act15]: mekA(K321A)	mekA	decreased aggregate size
DBS0350032	mekA-/ [act15]: mekA(S444A/ T448A)	mekA	decreased aggregate size
DBS0238109	mekA-/ ppp4C-/ [act15]: FLAG: pppC	ppp4c	decreased aggregate size \| precocious development
DBS0266674	mhcA-/ [act15]: GFP: abpC(9-148)	abpC \| mhcA	decreased uropod retraction \| decreased pseudopod retraction
DBS0266675	mhcA-/ [act15]: GFP: mhcA(E476K)	mhcA	decreased pseudopod retraction
DBS0350489	mhcA-/ [act15]: GFP: mhcA/ [RNAi]rmd1	mhcA \| rmd1	aberrant protein localization
DBS0236548	mhcA-/ [act15]: GFP: pats1(2087-2351)	mhcA \| pats1	aberrant cytokinesis
DBS0350291	mhcA-/ [act15]: gppA: GFP	gppA \| mhcA	aberrant contractile vacuole morphology \| decreased contractile vacuole discharge
DBS0236549	mhcA-/ [act15]: limE(1-145): GFP	limE \| mhcA	increased F-actin polymerization
DBS0350808	mhcA-/ [act15]: mhcA(1-933: 1455-2116]	mhcA	wild type \| aberrant cytokinesis \| aberrant fruiting body morphology
DBS0238158	mhcA-/ [act15]: mhcA(81-2116)	mhcA	decreased growth rate \| development arrests at tipped mound stage
DBS0236550	mhcA-/ [act15]: mhcA(T1823A/ T1833A/ T2029A)	mhcA	decreased filopodium formation
DBS0236551	mhcA-/ [act15]: mhcA(T1823D/ T1833D/ T2029D)	mhcA	increased filopodium formation
DBS0350948	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(E683K)	mhcA	aberrant catalytic activity
DBS0350949	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(R686C)	mhcA	aberrant catalytic activity
DBS0238157	mhcA-/ [mhcA]: mhcA(1-1224)/ [act15]: mhcA(R689H)	mhcA	decreased actin filament sliding
DBS0236557	mhkA-/ [act15]: mhkA	mhkA	decreased growth rate \| development arrests at mound stage \| aberrant cytokinesis \| decreased myosin II assembly
DBS0238058	mlcE-/ [act15]: myc: mlcE	mlcE	wild type
DBS0349919	mlkA-/ [act15]: GFP-mhcA	mlkA	aberrant stalk morphogenesis
DBS0266904	mpl1-/ [act15]: flag: mpl1	mpl1	wild type
DBS0350391	mrfA-/ [act15]: myc: mrfA(K772A): FLAG	mrfA	aberrant protein modification
DBS0350390	mrfA-/ [act15]: myc: mrfA(S767A): FLAG	mrfA	aberrant protein modification \| delayed development
DBS0350389	mrfA-/ [act15]: myc: mrfA: FLAG	mrfA	wild type
DBS0266889	myoI-/ [act15]: GFP: myoI	myoI	wild type
DBS0266890	myoI-/ [act15]: GFP: myoI(809-1154)	myoI	decreased phagocytosis
DBS0237617	myoI-/ [act15]: gbpD	gbpD \| myoI	increased pseudopod formation \| increased cell-substrate adhesion \| aberrant cell morphology
DBS0349846	myoK-/ [act15]: YFP: myoK(1-121: 262-858)	myoK	decreased phagocytosis
DBS0349850	myoK-/ [act15]: myoK	myoK	increased phagocytosis
DBS0349854	myoK-/ [act15]: pakB(1-337: 563-852)	myoK \| pakB	wild type
DBS0349841	nhe1-/ [act15]: mhcA: GFP	mhcA \| nhe1	aberrant protein localization
DBS0236611	noxA-/ [act15]: noxA: myc2	noxA	aberrant fruiting body morphology
DBS0350196	nsfA(A1854T, T1984A, C2131A, A2398T, T2574A)	nsfA \| pkaC	abolished SDF production
DBS0236702	nxnA-/ [act15]: GFP: nxnB	nxnA \| nxnB	development arrests at mound stage
DBS0238362	p2xA-/ [act15]: p2xA: GFP	p2xA	wild type
DBS0350014	pah-/ [act15]: 6xHis: pah	pah	wild type
DBS0350016	pah-/ [act15]: 6xHis: pah(92-415)	pah	abolished growth
DBS0350015	pah-/ [act15]: 6xHis: pah(92-441)	pah	wild type
DBS0350810	pakA-/ [act15]: pakA(T579A)	pakA	decreased chemotaxis to cAMP
DBS0349889	pakA-/ [act15]: pakA: GFP	pakA	wild type
DBS0350428	pakB-/ [act15]: RFP: abpE	abpE-1 \| abpE-2 \| pakB	aberrant establishment and/ or maintenance of cell polarity \| decreased chemotaxis to cAMP \| abolished aggregation \| aberrant protein localization
DBS0350430	pakB-/ [act15]: RFP: abpE/ [act15]: GFP: pak(1-180)	abpE-1 \| abpE-2 \| pakB	wild type
DBS0350282	pakD-/ [act15]: pakD	pakD	development arrests at mound stage
DBS0350395	pakD-/ [act15]: pakD: GFP	pakD	wild type
DBS0350973	paxB-/ [act15]: gpaH	gpaH \| paxB	aberrant cytokinesis
DBS0350094	paxB-/ [act15]: pldB	paxB \| pldB	wild type \| increased phagocytosis
DBS0350893	pdeD-/ pdeE-/ [unk]: pdeE	pdeD \| pdeE	delayed aggregation
DBS0236747	pefB-/ noxA-/ [act15]: pefB	noxA \| pefB	aberrant development
DBS0304869	phg1A-/ [act15]: phg1A(1-276): phg1B221-587)	phg1A \| phg1B	decreased phagocytosis
DBS0304868	phg1A-/ [act15]: phg1B	phg1A \| phg1B	increased secretion of lysosomal enzyme \| wild type \| decreased cell-substrate adhesion \| aberrant protein level \| decreased phagocytosis
DBS0304870	phg1A-/ [act15]: phg1B(1-220): phg1a(277-642)	phg1A \| phg1B	decreased phagocytosis
DBS0237615	phg2-/ [act15]: gbpD	gbpD \| phg2	increased pseudopod formation \| aberrant cell morphology \| abolished chemotaxis to cAMP
DBS0302610	phgA-/ [OE]: dsgg	dsgg \| phgA	aberrant contractile vacuole organization and biogenesis
DBS0350471	pikA-/ pikB-/ [act15]: GFP: cap	cap \| pikA \| pikB	wild type
DBS0350708	pkaC-/ [act6]: pkaC(303-648)	pkaC	wild type
DBS0350707	pkaC-/ [act6]: pkaC(330-648)	pkaC	abolished aggregation
DBS0350919	pkcA-/ [act15]: pldB	pkcA \| pldB	aberrant aggregation \| decreased sporulation
DBS0267125	plc-/ [OE]: dagA(PH): GFP/ [OE]: plc	dagA \| plc	increased CRAC localization to the plasma membrane \| decreased chemotaxis to cAMP \| aberrant protein localization
DBS0350047	plc-/ [act15]: pten: GFP	plc \| pten	wild type \| aberrant protein localization to cytoplasm
DBS0236797	pldB-/ [act15]: pldB: GFP	pldB	abolished aggregation
DBS0236825	ppk1-/ [act15]: ppk1	ppk1	wild type
DBS0238110	ppp4C-/ [act15]: smkA	ppp4c \| smkA	development arrests at mound stage \| delayed development
DBS0238034	proC-/ [unk]: FLAG: proC	proC	wild type
DBS0350305	psenA-/ psenB-/ [act15]: GFP: psenB	psenA \| psenB	wild type
DBS0350306	psenA-/ psenB-/ [act15]: psenB(D348A/ D394A)	psenA \| psenB	wild type
DBS0302356	psrA-/ [act15]: FLAG: gskA	gskA \| psrA	increased protein kinase activation
DBS0302357	psrA-/ [act15]: gskA(K84M/ K85M)	gskA \| psrA	decreased culmination \| decreased gene expression \| delayed development \| increased protein kinase activation
DBS0350829	psrA-/ [unk]: FLAG: rasD(G12T)	psrA \| rasD	increased protein kinase activation
DBS0350454	pten-/ [act15]: lpten: RFP	lpten \| pten	wild type
DBS0349890	pten-/ [act15]: pakA: GFP	pakA \| pten	aberrant cytokinesis
DBS0350754	pten-/ [act15]: pten(186-515): GFP	pten	decreased chemotaxis to cAMP \| aberrant development
DBS0350755	pten-/ [act15]: pten(C124S): GFP	pten	decreased chemotaxis to cAMP \| aberrant development
DBS0236831	pten-/ [act15]: pten: GFP	pten	wild type
DBS0349893	pten-/ pakA-/ [act15]: pakA(T585A): GFP	pakA \| pten	decreased chemotaxis to cAMP
DBS0349900	pten-/ pakA-/ [act15]: pakA(T585E): GFP	pakA \| pten	aberrant cytokinesis \| decreased chemotaxis to cAMP
DBS0349899	pten-/ pakA-/ [act15]: pakA: GFP	pakA \| pten	aberrant cytokinesis
DBS0350675	ptpB-/ [act15]: 6xHis: erkA	erkA \| ptpB	aberrant streaming
DBS0350018	qdpr-/ [act15]: pah	pah \| qdpr	decreased growth rate
DBS0350011	qkgA-/ [act15]: bzpN: GFP	bzpN \| qkgA-1 \| qkgA-2	abolished negative regulation of vegetative growth
DBS0237191	racC-/ [act15]: CFP: racC	racC	increased chemoattractant-mediated F-actin polymerization
DBS0349949	racE-/ [act15]: fttB	fttB \| racE	decreased growth rate
DBS0349946	racE-/ [act15]: fttB: GFP	fttB \| racE	abolished protein localization to cell cortex
DBS0350956	racE-/ [act15]racE(G20V)	racE	wild type
DBS0350957	racE-/ [act15]racE(T25N)	racE	abolished cytokinesis
DBS0350317	rapgap9-/ [act15]: GFP: rapgap9	rapgap9	wild type
DBS0237614	rasC-/ [act15]: gbpD	gbpD \| rasC	increased cell-substrate adhesion \| aberrant cell morphology
DBS0350740	rasC-/ [rasC]: rasG	rasC \| rasG	abolished activation of adenylate cyclase \| abolished aggregation
DBS0350742	rasC-/ [rasC]: rasG(1-77(D30A)): rasC(79-189)	rasC \| rasG	wild type
DBS0350741	rasC-/ [rasC]: rasG(D30A)	rasC \| rasG	aberrant aggregation \| decreased activation of adenylate cyclase
DBS0266697	rasC-/ rasG-/ [act15]: carA	carA-1 \| carA-2 \| rasC \| rasG	abolished growth \| abolished activation of GTPase activity \| decreased growth rate \| decreased activation of adenylate cyclase \| abolished protein kinase activation \| abolished cAMP-induced cGMP pulse \| abolished chemotaxis to cAMP
DBS0350480	rasC-/ rasG-/ [rasG]: rasD	rasC \| rasD \| rasG	decreased chemotaxis to folate
DBS0350482	rasC-/ rasG-/ [rasG]: rasD(1-104): rasG(103-189)	rasC \| rasD \| rasG	decreased chemotaxis to folate
DBS0350481	rasC-/ rasG-/ [rasG]: rasG	rasC \| rasG	wild type
DBS0350483	rasC-/ rasG-/ [rasG]: rasG(1-104): rasD(103-187)	rasC \| rasD \| rasG	wild type
DBS0236859	rasD(G12T)	rasD	development arrests at mound stage \| development arrests at tipped mound stage
DBS0236864	rasG-/ [OE]: rasB	rasB \| rasG	decreased growth rate
DBS0350448	rasG-/ [dscB]: rasG(S17N)	rasG	decreased chemoattractant-mediated F-actin polymerization \| decreased positive regulation of GTPase activity \| decreased protein kinase activation \| decreased chemotaxis to cAMP
DBS0349996	rblA-/ [act15]: GFP/ [act15]: myc: btg	btg \| rblA	increased sorting to prestalk region
DBS0235706	regA-/ [act15]: dhkK(D1125N)	dhkK \| regA	precocious development \| aberrant fruiting body morphology
DBS0349921	rgaA-/ [act15]: GFP-mhcA	rgaA	aberrant stalk morphogenesis \| aberrant tip formation \| aberrant protein localization
DBS0350020	rgfA-/ [act15]: rgfA	rgfA	decreased chemotaxis to folate \| delayed development
DBS0350193	ric8-/ [act15]: GFP: ric8	ric8	wild type
DBS0350219	rrpC-/ [act15]: pre-miRNA	rrpC	increased microRNA processing
DBS0350974	sadA-/ [act15]: gpaH	gpaH \| sadA	aberrant cytokinesis
DBS0349927	scrA-/ [act15]: wasA: GFP/ [ act8]: RFP: arcD	scrA	decreased cell polarity \| decreased pseudopod formation
DBS0349957	sma-/ ampA/ [ampA]: ampA	ampA \| sma	decreased chemotaxis to folate
DBS0350637	tagB-/ [pkaC]: pkaC	pkaC \| tagB	abolished SDF-1 production \| aberrant response to SDF-1
DBS0350698	tagC-/ [pkaC]: pkaC	pkaC \| tagC	development arrests at mound stage \| abolished SDF-2 production
DBS0236976	talA-	talA	decreased protein level \| decreased cell-substrate adhesion \| aberrant cytokinesis \| decreased phagocytosis \| aberrant cell morphology
DBS0304585	talA-/ [act15]: FLAG: talB	talA \| talB	decreased cell-substrate adhesion
DBS0237616	talA-/ [act15]: gbpD	gbpD \| talA	increased pseudopod formation \| increased cell-substrate adhesion \| aberrant cell morphology
DBS0238395	talA-/ [act15]: rapA(G12V)	rapA \| talA	increased cell-substrate adhesion
DBS0304582	talA-/ talB-/ [act15]: FLAG: talB	talA \| talB	wild type
DBS0350713	talA-/ talB-/ [act15]: talB(K16A)	talA \| talB	decreased cell-substrate adhesion
DBS0304586	talB-/ [act15]: talA: GFP	talA \| talB	aberrant fruiting body morphology
DBS0350712	talB-/ [act15]: talB(K16A)	talB	development arrests at tipped mound stage
DBS0350729	tipC-/ [unk]: tipC(2725-3848): GFP	tipC	decreased fruiting body size
DBS0350505	tpp1-/ [cotB]: tpp1	tpp1	wild type
DBS0302383	tsuA-/ [unk]: tsuA(1-1774): YFP	tsuA	abolished localization to microtubules \| decreased aggregate size \| abolished localization to microtubule organizing center \| decreased fruiting body size
DBS0302385	tsuA-/ [unk]: tsuA(1-260): YFP	tsuA	abolished localization to microtubules \| abolished localization to microtubule organizing center \| decreased aggregate size \| decreased fruiting body size
DBS0302384	tsuA-/ [unk]: tsuA(1774-2247): YFP	tsuA	abolished localization to microtubules \| abolished localization to microtubule organizing center \| decreased aggregate size \| decreased fruiting body size
DBS0302382	tsuA-/ [unk]: tsuA(K34R): YFP	tsuA	decreased aggregate size \| decreased fruiting body size
DBS0237033	vasP-/ [act15]: GFP: vasP(1-264/ 285-380)	vasP	abolished filopodium formation
DBS0237836	vasP-/ [act15]: YFP: wipA	vasP \| wipA	decreased filopodium formation
DBS0237842	vasP-/ [act15]: YFP: wipA/ [act15]: vasP: FLAG	vasP \| wipA	increased filopodium formation
DBS0237040	vasP-/ [act15]: vasP	vasP	decreased filopodium formation
DBS0237840	vasP-/ [act15]: vasP	vasP	increased filopodium formation \| increased basal F-actin level
DBS0237037	vasP-/ [act15]: vasP(1-110: 231-380)	vasP	increased basal F-actin level \| aberrant cytokinesis \| decreased filopodium formation
DBS0237038	vasP-/ [act15]: vasP(1-228)	vasP	decreased filopodium formation
DBS0237039	vasP-/ [act15]: vasP(111-380)	vasP	increased filopodium formation \| increased basal F-actin level
DBS0350466	vasP-/ [unk]: vasP(1-197: 221-380)	vasP	wild type
DBS0350467	vasP-/ [unk]: vasP(1-261: 285-380)	vasP	decreased cell motility \| abolished filopodium formation
DBS0350290	vwkA-/ [act15]: GFP: mhcA	mhcA \| vwkA	aberrant myosin II organization
DBS0237812	wasA1-/ [tet]: YFP: wasA2/ [act15]: wasA	wasA	increased F-actin polymerization at the leading edge
DBS0237811	wasA1-/ [tet]: YFP: wasA2/ [act15]: wasA(Y33A/ W39A/ F90A/ F91A)	wasA	decreased F-actin polymerization \| decreased F-actin polymerization at the leading edge
DBS0237820	wasA1-/ [tet]: YFP: wasA2/ [act15]: wipA	wasA \| wipA	abolished positive chemotaxis
DBS0350255	wasB-/ [act15]: YFP: wasB	wasB	wild type
DBS0350247	wshA-/ fam21-/ [act15]: GFP: wshA	fam21 \| wshA	aberrant post-lysosome organization and biogenesis
DBS0350944	xacA-/ [act15]: xacA(1-320)	xacA	decreased growth rate \| aberrant cytokinesis
DBS0350945	xacA-/ [act15]: xacA(779-1335)	xacA	decreased response to hypo-osmotic stress \| aberrant contractile vacuole morphology
DBS0237091	yakA-/ [crlA]: crlA	crlA \| yakA	abolished growth
DBS0349882	zak2-/ [ecmA]: zakA	zak2 \| zakA	aberrant gene expression

Last updated August 28, 2017


		Genomes Dictyostelium discoideum Dictyostelium purpureum Dictyostelium fasciculatum Polysphondylium pallidum Explore Learn About Dicty Teaching Protocols Dictyostelium Genome Resources D. discoideum Genome Statistics Pictures/Videos dictyArt Useful Links Virtual Library Dictyostelium Page Research Techniques Dicty Anatomy Ontology Mutant Phenotypes HTP Phenotyping at Princeton Codon Bias Table Nomenclature Guidelines Axenic Strains History Franke Dictyostelium Reference Library Tools New JBrowse Genome Browser Chromosome 1 Chromosome 2 Chromosome 3 Chromosome 4 Chromosome 5 Chromosome 6 Mitochondrial DNA Ribosomal DNA Legacy Genome Browser Chromosome 1 Chromosome 2 Chromosome 3 Chromosome 4 Chromosome 5 Chromosome 6 Mitochondrial DNA Ribosomal DNA BLAST ID Converter dictyMart Textpresso Biochemical Pathways Third Party Tools Stock Center Dicty Stock Center Home About Stock Center Search Stock Center Order Deposit Strain Catalog Plasmid Catalog Additional Materials Stock Center FAQ Nomenclature Guidelines Other Stock Centers Download Community Submit an Abstract to dictyNews Read the dictyNews ListServ Archive Add or update your colleague profile Dicty Annual Conference Job opportunities History Dicty Labs on the Web Citing dictyBase and the Dictyostelium Genome Project		About Us Contact Help